skip to content
Drug Treatments for Crohn's Disease
Follow the links below to find information about drug treatments for Crohn's Disease.
Reviewed May 2012
23 Resources Found
Results 1 to 20 displayed. 1 2
| Title: | Sargramostim (GM-CSF) for induction of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic inflammatory condition of the gut. New theories regarding the cause of this inflammation has led some investigators to think it is a weak immune system, rather than an overactive one, that leads to this condition. They teste... |
| Date: | Apr 2011 |
| Title: | Interleukin 10 (IL-10) for induction of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is an inflammatory condition of unknown origin that can affect any portion of the gastrointestinal tract from the mouth to the anus. However, it most commonly involves the distal small bowel and/or the colon. Interleukin 10 does not appe... |
| Date: | Sep 2010 |
| Title: | Aminosalicylates for treatment of active Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic inflammatory disease of the intestines. Although Crohn's disease is often found in the ileum (the lower part of the small intestine), it can occur in any part of the digestive tract, from the mouth to the anus. The most comm... |
| Date: | Jul 2010 |
| Title: | Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Prevention of relapse is a key objective in the management of Crohn's disease. There is no current treatment available that completely maintains remission and is without significant side-effects. 5-ASA (aminosalicylic acid) preparations have previousl... |
| Date: | May 2010 |
| Title: | Remicade for treatment of Crohn's Disease - myDr.com.au |
|---|---|
| Publisher: | myDr |
| Description: | Remicade is the Australian brand name for a medicine called infliximab, which is used to treat Crohn's disease and some other autoimmune conditions. |
| Date: | Feb 2010 |
| Title: | Azathioprine or 6-mercaptopurine for the treatment of active Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Azathioprine and 6-mercaptopurine may be effective for inducing remission in Crohn's disease among patients with chronically active disease. These drugs may reduce the need for steroid treatment and their use may therefore lead to a lower incidence of s... |
| Date: | Jul 2009 |
| Title: | Methotrexate for treatment of inactive Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic inflammatory disease of the intestines that frequently occurs in the lower part of the small intestine, called the ileum. However, Crohn's disease can affect any part of the digestive tract, from the mouth to the anus. The... |
| Date: | Apr 2009 |
| Title: | Crohn's disease treatments - myDr.com.au |
|---|---|
| Publisher: | myDr |
| Description: | Medical treatment aims to control Crohn's disease symptoms and bring on a remission of the disease. |
| Date: | Mar 2009 |
| Title: | Interventions for prevention of post-operative recurrence of Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic illness where patients suffer from diarrhea, weight loss or stomach pain resulting from inflammation in the intestine. The illness often requires patients to undergo surgery in order to remove inflamed segments of intestine,... |
| Date: | Feb 2009 |
| Title: | Thalidomide for maintenance of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Prevention of relapse is a key objective in the management of Crohn's disease. There is no current treatment available that completely maintains remission and is without significant side-effects. Thalidomide is sometimes used in clinical practice to att... |
| Date: | Sep 2008 |
| Title: | Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Azathioprine (1.0 to 2.5 mg/kg/day) used among patients with non-active Crohn's disease is effective for reducing the risk of disease recurrence over a 6 month to 2 year period. Higher doses of azathioprine (2.5 mg/kg/day) are more effective than lower ... |
| Date: | Aug 2008 |
| Title: | Budesonide for maintenance of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Budesonide is a newer corticosteroid drug which is rapidly metabolized by the liver thereby reducing corticosteroid related side effects. Research showing that budesonide is effective in treating active Crohn's disease has led to trials examining the ef... |
| Date: | Aug 2008 |
| Title: | Thalidomide for induction of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic inflammatory disorder of the bowel. Thalidomide may help to reduce inflammation in the gut and might be effective for the treatment of Crohn's disease. One randomised controlled trial on the use of thalidomide for the treatm... |
| Date: | Aug 2008 |
| Title: | Corticosteroids for maintenance of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | The use of corticosteroids among patients with non-active Crohn's disease does not appear to be effective in reducing the risk of disease recurrence over a 24 month period. Side effects associated with the long term use of corticosteroids include osteop... |
| Date: | Jul 2008 |
| Title: | Corticosteroids for induction of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Corticosteroids have been used for decades to treat active Crohn's disease. Controlled clinical studies that evaluated the effect of systemic corticosteroids to induce remission in Crohn's disease were reviewed. For inclusion in this analysis, studies c... |
| Date: | Feb 2008 |
| Title: | Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Crohn's disease is a chronic inflammatory disease of the intestines. Crohn's disease frequently occurs in the lower part of the small intestine (the ileum), however it can affect any part of the digestive tract, from the mouth to the anus. The most comm... |
| Date: | Oct 2007 |
| Title: | Enteral nutritional therapy for treatment of active Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Evidence continues to indicate that corticosteroids are more effective than enteral nutrition (liquid food) for treating active Crohn's disease. Comparing one form of enteral nutrition to another has not shown any difference in effectiveness for treatin... |
| Date: | Oct 2006 |
| Title: | Interventions for growth failure in childhood Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Growth failure occurs in 15-40% of children with Crohn's disease. Growth in affected children is influenced by the disease process itself and by some treatments. Management in children differs from that in adults because of the required emphasis on achi... |
| Date: | May 2005 |
| Title: | Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Prevention of relapse is a key objective in the management of Crohn's disease. There is no current treatment available that completely maintains remission and is without significant side-effects. 5-ASA (aminosalicylic acid) preparations are frequently u... |
| Date: | Nov 2004 |
| Title: | Methotrexate for treatment of active treatment resistant Crohn's disease |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Although corticosteroids are effective for treating Crohn's disease, approximately 20% of patients who respond become sick again when steroids are withdrawn and become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. ... |
| Date: | Jul 2004 |
Results 1 to 20 displayed. 1 2
